Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial

Antonio Landi, Nuccia Morici, Pascal Vranckx, Enrico Frigoli, Luca Bonacchini, Barbara Omazzi, Moreno Tresoldi, Claudio Camponovo, Tiziano Moccetti, Marco Valgimigli

Open source

DOI
10.2459/jcm.0000000000001556
Published
2023-11-03
Container
Journal of Cardiovascular Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2459/jcm.0000000000001556,
  title = {Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial},
  author = {Antonio Landi and Nuccia Morici and Pascal Vranckx and Enrico Frigoli and Luca Bonacchini and Barbara Omazzi and Moreno Tresoldi and Claudio Camponovo and Tiziano Moccetti and Marco Valgimigli},
  year = {2023},
  journal = {Journal of Cardiovascular Medicine},
  doi = {10.2459/jcm.0000000000001556},
  url = {https://doi.org/10.2459/jcm.0000000000001556}
}

RIS

TY  - JOUR
TI  - Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial
AU  - Antonio Landi
AU  - Nuccia Morici
AU  - Pascal Vranckx
AU  - Enrico Frigoli
AU  - Luca Bonacchini
AU  - Barbara Omazzi
AU  - Moreno Tresoldi
AU  - Claudio Camponovo
AU  - Tiziano Moccetti
AU  - Marco Valgimigli
PY  - 2023
JO  - Journal of Cardiovascular Medicine
DO  - 10.2459/jcm.0000000000001556
UR  - https://doi.org/10.2459/jcm.0000000000001556
ER  - 

APA

Landi, A., Morici, N., Vranckx, P., Frigoli, E., Bonacchini, L., Omazzi, B., Tresoldi, M., Camponovo, C., Moccetti, T., & Valgimigli, M. (2023). Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0000000000001556

Source records